Abstract:
Material and methods: We observed with HCV 30 patients in the clinic of the Tashkent medical academy. All patients were diagnosed with HCV-associated arthritis (HCVaA). The patients were divided into 2 groups of 15 people. In the first group patients were given aceclofenac, the second — meloxicam. The clinical picture of joint syndrome was evaluated in dynamics, and blood biochemical parameters were monitored